Thomas Andrew Davis, Executive VP & CMO at Celldex, holds 68.33K shares in Genocea Biosciences (Ticker: GNCAQ), holds 1.01K shares in Celldex (Ticker: CLDX), holds 5.00K shares in GenVec Inc (Ticker: GNVC). Most recently, Thomas Andrew Davis Sold ― shares of Genocea Biosciences on Apr 05, 2022 for an estimated value of 1.36K.